XML 157 R143.htm IDEA: XBRL DOCUMENT v3.20.2
Subsequent Events (Details Narrative) (Brooklyn ImmunoTherapeutics, LLC) - USD ($)
Aug. 12, 2020
Jul. 08, 2020
Jul. 08, 2020
Jul. 07, 2020
Jun. 30, 2020
Dec. 31, 2019
Jun. 30, 2019
Dec. 31, 2018
Equity ownership, percentage           51.00%    
Cash and cash equivalents         $ 2,234,000 $ 3,209,000 $ 2,727,000 $ 2,536,000
Brooklyn Immunotherapeutics, LLC [Member]                
Cash and cash equivalents         $ 5,186,675  
Brooklyn Immunotherapeutics, LLC [Member] | Subsequent Event [Member] | BIT Merger Sub, Inc [Member]                
Agreement, description       BITX settled an ongoing dispute with USF for $150,000). In addition, a payment of $56,738 was made for outstanding invoices        
Outstanding invoice, payments       $ 56,738        
Brooklyn Immunotherapeutics, LLC [Member] | Subsequent Event [Member] | MergerAgreement with NTN Buzztime, Inc [Member]                
Equity ownership, percentage 5.92%              
Other party, termination fees $ 750,000              
Brooklyn Immunotherapeutics, LLC [Member] | Subsequent Event [Member] | MergerAgreement BIT Merger Sub, Inc [Member]                
Equity ownership, percentage 94.08%              
Brooklyn Immunotherapeutics, LLC [Member] | Subsequent Event [Member] | Right Offering [Member] | BIT Merger Sub, Inc [Member]                
Cash and cash equivalents $ 10,000,000              
Brooklyn Immunotherapeutics, LLC [Member] | Subsequent Event [Member] | Employee Agreements [Member] | BIT Merger Sub, Inc [Member] | January 8, 2021 [Member]                
Employee, retention payment   $ 200,000            
Brooklyn Immunotherapeutics, LLC [Member] | Subsequent Event [Member] | Employee Agreements [Member] | BIT Merger Sub, Inc [Member] | July 8, 2021 [Member]                
Employee, retention payment     $ 200,000